IMMUNO-ONCOLOGY CLINICAL NETWORK

ioclinicalnetwork.co.uk

The Immuno-Oncology Clinical Network (IOCN) supports health care professionals delivering immuno-oncology therapies to improve patient care through clinical support, education, service development and governance. The IOCN also promotes and support research or any activities that will progress knowledge and understanding of immuno-oncology treatments and the associated side effects.
1205140
IČO
2023
Založeno
L222AA
Adresa
ioclinicalnetwork.co.uk
Web

Poslední komentáře

💙 So proud to support the incredible work of the Immuno-Oncology Clinical Network! Together, we can make a difference in the lives of those battling cancer. Let's continue to improve patient care and support our healthcare heroes! 🌟 #IOClinicalNet #Immunotherapy
detail
👏 Amazing initiatives from Dr. Anna Olsson-Brown and the entire IOCN team! It's inspiring to see a community dedicated to empowering healthcare professionals and enhancing the treatment experience for patients. Keep up the fantastic work! 💪 #CancerCare #ImmunoOncology
detail

Poslední diskuze

1. What strategies can the Immuno-Oncology Clinical Network implement to enhance awareness and understanding of immunotherapy among healthcare professionals and the general public?
Odpovědí: 3, Naposledy před 1 den detail
2. How can we effectively address and manage the immune-mediated side effects of immunotherapy to improve patient outcomes and quality of life?
Odpovědí: 3, Naposledy před 1 den detail

V okolí

Kontaktovat
IMMUNO-ONCOLOGY CLINICAL NETWORK logo
IMMUNO-ONCOLOGY CLINICAL NETWORK
+ Sledovat
4.5
Reviews
L222AA
Místo
O společnosti

- E31, E20, H30 -

IOClinicalNet IOCN The ImmunoOncology Clinical Network Upcoming IOCN Events IOCN WEBINARS Supporting those receiving immunotherapy by supporting those delivering it Our Ethos Dr Anna OlssonBrown IOCN Founder and CEO Our mission is to build an ImmunoOncology IO community to improve patient care. Immunotherapy has revolutionised cancer care and is increasingly used to treat cancer in the curative and palliative setting. Despite advances in Immunooncology treatments many challenges remain including the immunemediated side effects from treatment that hinder its use. We support all healthcare professionals involved in caring for patients receiving immunotherapy to help address these challenges.

Skupinová zdravotní praxe (HMO) Nemocnice a zařízení primární zdravotní péče Výzkum rakoviny
23 Vacancy More Detail